CEO Shift and Guidance Cuts Contrast With Surging AI and FedRAMP Gains

Source: Biztoc.com· finance.yahoo.com· August 21, 2026
CEO Shift and Guidance Cuts Contrast With Surging AI and FedRAMP Gains

On August 13, Cellebrite (NASDAQ:CLBT) named a new chief executive and trimmed its full-year outlook on the same morning. Shiven Ramji stepped in as CEO effective that day, replacing Tom Hogan, while the company lowered its 2026 revenue and ARR targets after …

This story was reported by Biztoc.com. Read the full original article:
Read on Biztoc.com

More in Business & Funding

View all